Results 201 to 210 of about 7,567,038 (395)

Improving Reporter Gene Assay Methodology for Evaluating the Ability of Compounds to Restore P53 Activity. [PDF]

open access: yesInt J Mol Sci, 2022
Han X   +10 more
europepmc   +1 more source

Dual reporter genes enabling cell tracing with viable and reliable selection of various cell types [PDF]

open access: bronze, 2006
C. N. Hwang   +5 more
openalex   +1 more source

Inhibition of CDK9 enhances AML cell death induced by combined venetoclax and azacitidine

open access: yesMolecular Oncology, EarlyView.
The CDK9 inhibitor AZD4573 downregulates c‐MYC and MCL‐1 to induce death of cytarabine (AraC)‐resistant AML cells. This enhances VEN + AZA‐induced cell death significantly more than any combination of two of the three drugs in AraC‐resistant AML cells.
Shuangshuang Wu   +18 more
wiley   +1 more source

Pre-validation of a reporter gene assay for oxidative stress for the rapid screening of nanobiomaterials. [PDF]

open access: yesFront Toxicol, 2022
Martin S   +26 more
europepmc   +1 more source

Figure S5 from PET Reporter Gene Imaging and Ganciclovir-Mediated Ablation of Chimeric Antigen Receptor T Cells in Solid Tumors

open access: gold, 2023
Surya Murty   +13 more
openalex   +1 more source

3D chromatin structure and massively parallel reporter assays in hiPSC‐derived microglia and human macrophages identifies novel putative Alzheimer’s Disease risk genes [PDF]

open access: bronze, 2023
Ivana Yoseli Quiroga   +9 more
openalex   +1 more source

Evaluating the microRNA targeting sites by luciferase reporter gene assay.

open access: yesMethods in molecular biology, 2013
Yi Jin   +3 more
semanticscholar   +1 more source

A synthetic benzoxazine dimer derivative targets c‐Myc to inhibit colorectal cancer progression

open access: yesMolecular Oncology, EarlyView.
Benzoxazine dimer derivatives bind to the bHLH‐LZ region of c‐Myc, disrupting c‐Myc/MAX complexes, which are evaluated from SAR analysis. This increases ubiquitination and reduces cellular c‐Myc. Impairing DNA repair mechanisms is shown through proteomic analysis.
Nicharat Sriratanasak   +8 more
wiley   +1 more source

Adaptaquin is selectively toxic to glioma stem cells through disruption of iron and cholesterol metabolism

open access: yesMolecular Oncology, EarlyView.
Adaptaquin selectively kills glioma stem cells while sparing differentiated brain cells. Transcriptomic and proteomic analyses show Adaptaquin disrupts iron and cholesterol homeostasis, with iron chelation amplifying cytotoxicity via cholesterol depletion, mitochondrial dysfunction, and elevated reactive oxygen species.
Adrien M. Vaquié   +16 more
wiley   +1 more source

Home - About - Disclaimer - Privacy